Effect of Poge Jiuxin Decoction combined with β-blocker on the treatment of angina pectoris of coronary heart disease with qi stagnation and blood stasis syndrome and its anti-oxidation ability
SHU Lili1 SONG Yingjing2 SHAO Yunfei3
1.Graduate School, Zhejiang Chinese Medical University, Zhejiang Province, Hangzhou 310053, China;
2.Department of Cardiovascular Medicine, Linhai Hospital of Traditional Chinese Medicine Medical and Health Service Community, Zhejiang Province, Linhai 317000, China;
3.Department of Cardiovascular Medicine, Sanmen People’s Hospital, Zhejiang Province, Sanmen 317100, China
Abstract：Objective To explore the effect of Poge Jiuxin Decoction combined with β-blocker on the treatment of angina pectoris of coronary heart disease with qi stagnation and blood stasis syndrome and its anti-oxidation ability. Methods A total of 168 patients with angina pectoris of coronary heart disease with qi stagnation and blood stasis syndrome were selected from the Linhai Hospital of Traditional Chinese Medicine Medical and Health Service Community of Zhejiang Province from March 2019 to March 2021, and they were divided into β-blocker group, Poge Jiuxin Decoction group, and combined drug group according to random number table method, with 56 cases in each group. Brain natriuretic peptide (BNP), cardiac troponin I(cTnI), creatine kinase-MB (CK-MB), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), nitric oxide (NO), superoxide dismutase (SOD), malondialdehyde (MDA), glutathione peroxidase (GSH-Px), lipid hydroperoxide (LPO), traditional Chinese medicine syndrome score, and traditional Chinese medicine syndrome efficacy were observed in the three groups before treatment and two weeks after treatment. Results After treatment, the levels of BNP, cTnI, and CK-MB in the three groups were lower than before treatment, and those in the combined drug group were lower than those in the β-blocker group and the Poge Jiuxin Decoction group (P＜0.05). After treatment, the levels of TNF-α and IL-6 in the three groups were lower than before treatment, and those in the combined drug group were lower than those in the β-blocker group and the Poge Jiuxin Decoction group (P＜0.05); the level of NO in the three groups was higher than that before treatment, and that in the combined drug group was higher than that in the β-blocker group and the Poge Jiuxin Decoction group (P＜0.05). After treatment, the levels of SOD and GSH-Px in the three groups were higher than before treatment, and those in the combined drug group were higher than those in the β-blocker group and the Poge Jiuxin Decoction group (P＜0.05); the levels of MDA and LPO in the three groups were lower than before treatment, and those in the combined drug group were lower than those in the β-blocker group and the Poge Jiuxin Decoction group (P＜0.05). After treatment, the scores of angina pectoris, limb numbness, subcutaneous ecchymosis, and emotional abnormality in the three groups were lower than before treatment, and those in the combined drug group was lower than those in the β-blocker group and the Poge Jiuxin Decoction group (P＜0.05). The curative effect of traditional Chinese medicine syndrome in the combined drug group was higher than that in the β-blocker group and the Poge Jiuxin Decoction group (P＜0.05). Conclusion Qi stagnation and blood stasis syndrome patients with angina pectoris of coronary heart disease by the combination of the Poge Jiuxin Decoction and β-blocker can effectively improve the myocardial injury and inflammation of the body, enhance the antioxidant capacity, and achieve good results in clinical treatment.
舒礼礼1 宋迎婧2 邵云飞3. 破格救心汤联合β-受体阻滞剂治疗气滞血瘀证冠心病心绞痛患者的效果及对抗氧化能力的影响[J]. 中国医药导报, 2023, 20(24): 130-135.
SHU Lili1 SONG Yingjing2 SHAO Yunfei3. Effect of Poge Jiuxin Decoction combined with β-blocker on the treatment of angina pectoris of coronary heart disease with qi stagnation and blood stasis syndrome and its anti-oxidation ability. 中国医药导报, 2023, 20(24): 130-135.
京公网安备 11010502046598号